These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2876445)
21. Classification of neuroleptics: implications for tardive dyskinesia. Christensen AV Pol J Pharmacol Pharm; 1985; 37(3):295-309. PubMed ID: 2866499 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972 [TBL] [Abstract][Full Text] [Related]
23. Interaction between aminergic systems in mesolimbic structures: the importance of 5-HT2, D2 and D1 receptors in the olfactory tubercle for the atypical profile of neuroleptics. Cools AR; Prinssen E; Ellenbroek BA Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():618A-619A. PubMed ID: 1354068 [TBL] [Abstract][Full Text] [Related]
24. Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Miller R; Wickens JR; Beninger RJ Prog Neurobiol; 1990; 34(2):143-83. PubMed ID: 1969668 [No Abstract] [Full Text] [Related]
35. Neuroleptics and the ability of animals to experience pleasure. Thiebot MH; Guyon A; Assouly-Besse F; Biala G; Puech AJ Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():552A-553A. PubMed ID: 1354063 [No Abstract] [Full Text] [Related]
36. The effect of 2-substitution on conformations and brain concentrations of phenothiazine-neuroleptics in relation to dopamine-antagonism. Grol CJ; Rollema H; Asselbergs HW J Pharm Pharmacol; 1979 Oct; 31(10):667-71. PubMed ID: 41038 [No Abstract] [Full Text] [Related]
37. The effect of neuroleptics on cognition and diagnosis, and their influence on stereotypies. Campbell M J Ment Defic Res; 1987 Jun; 31 ( Pt 2)():220-5. PubMed ID: 2887661 [No Abstract] [Full Text] [Related]
38. Dopamine receptor diversity: molecular and pharmacological perspectives. Hartman DS; Civelli O Prog Drug Res; 1997; 48():173-94. PubMed ID: 9204687 [No Abstract] [Full Text] [Related]
39. Fencamfamine. DeLucia R; Planeta CS Gen Pharmacol; 1990; 21(2):161-3. PubMed ID: 1970543 [TBL] [Abstract][Full Text] [Related]
40. Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Waddington JL; O'Boyle KM Pharmacol Ther; 1989; 43(1):1-52. PubMed ID: 2675127 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]